Pacific Shuanglin Bio-pharmacy (000403.SZ) plans for some of its directors, supervisors, high-level executives, and core management personnel to increase their holdings of the company's shares by no less than 5 million yuan.

Pacific Shuanglin Bio-pharmacy (000403.SZ) announced that the company has recently received notifications from some of the company's directors, supervisors, senior officers, and core management personnel about their voluntary plan to increase their holdings of the company's shares. Based on their confidence in the company's future development prospects and their high recognition of the company's value, in order to promote the healthy and stable long-term development of the company, safeguard the interests of shareholders, and enhance investor confidence, the company plans to use its own funds to increase its holdings of the company's shares through the Shenzhen Stock Exchange trading system within 6 months from the date of this announcement. The total amount of the increase shall not be less than RMB 5 million, and there is no set price range for this increase plan. The implementation of this increase plan will be carried out opportunistically based on the fluctuations in the company's stock price and the overall trend of the capital market.